0001453687-21-000081.txt : 20210603
0001453687-21-000081.hdr.sgml : 20210603
20210603163028
ACCESSION NUMBER: 0001453687-21-000081
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210601
FILED AS OF DATE: 20210603
DATE AS OF CHANGE: 20210603
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brunn Carsten
CENTRAL INDEX KEY: 0001760229
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37798
FILM NUMBER: 21992863
MAIL ADDRESS:
STREET 1: C/O SELECTA BIOSCIENCES, INC.
STREET 2: 480 ARSENAL WAY
CITY: WATERTOWN
STATE: MA
ZIP: 02472
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SELECTA BIOSCIENCES INC
CENTRAL INDEX KEY: 0001453687
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 65 GROVE STREET
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-923-1400
MAIL ADDRESS:
STREET 1: 65 GROVE STREET
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
wf-form4_162275218310282.xml
FORM 4
X0306
4
2021-06-01
0
0001453687
SELECTA BIOSCIENCES INC
SELB
0001760229
Brunn Carsten
C/O SELECTA BIOSCIENCES, INC.
65 GROVE STREET
WATERTOWN
MA
02472
1
1
0
0
President and CEO
Common Stock
2021-06-01
4
M
0
10938
0
A
227764
D
Common Stock
2021-06-02
4
S
0
4806
4.378
D
222958
D
Restricted Stock Units
2021-06-01
4
M
0
10938
0
D
Common Stock
10938.0
65625
D
Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.
The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $4.34 to $4.385. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Each restricted stock unit represents a contingent right to receive one share of common stock.
This restricted stock unit vested as to 25% on December 1, 2019 and has vested, and will continue to vest, as to an additional 8.33% each quarter thereafter until fully vested. The restricted stock units have no expiration date.
/s/ Matthew Bartholomae, Attorney-in-Fact for Carsten Brunn
2021-06-03